Amgen Announces One-Time Cash Payment and Additional Put Right for Liquid Yield Option Notes Due 2032 Read more about Amgen Announces One-Time Cash Payment and Additional Put Right for Liquid Yield Option Notes Due 2032
Treatment with ENBREL Had a Positive Effect on Activities of Daily Living for Patients with Psoriasis Read more about Treatment with ENBREL Had a Positive Effect on Activities of Daily Living for Patients with Psoriasis
Following Complete Review of Phase 2 Trial Data Amgen Confirms Decision to Halt GDNF Study; Comprehensive Review of Scientific Findings, Patient Safety, Drove Decision Read more about Following Complete Review of Phase 2 Trial Data Amgen Confirms Decision to Halt GDNF Study; Comprehensive Review of Scientific Findings, Patient Safety, Drove Decision
Amgen Announces Put Option Notification for Liquid Yield Option Notes Due 2032 Read more about Amgen Announces Put Option Notification for Liquid Yield Option Notes Due 2032
Amgen's Fourth Quarter 2004 Adjusted Earnings Per Share Increased 26 Percent to 58 Cents; Full Year 2004 Adjusted Earnings Per Share Increased 26 Percent to $2.40 Read more about Amgen's Fourth Quarter 2004 Adjusted Earnings Per Share Increased 26 Percent to 58 Cents; Full Year 2004 Adjusted Earnings Per Share Increased 26 Percent to $2.40
Amgen Significantly Expands Support of Patient Assistance Programs; Financial Support To Help Ensure Patients Have Access To Innovative Therapies Critical To Care Read more about Amgen Significantly Expands Support of Patient Assistance Programs; Financial Support To Help Ensure Patients Have Access To Innovative Therapies Critical To Care
Amgen Donates $1 Million and Establishes Tsunami Relief Program; Staff Donations, Company Contributions To Help South Asia Victims Read more about Amgen Donates $1 Million and Establishes Tsunami Relief Program; Staff Donations, Company Contributions To Help South Asia Victims
FDA Approves Kepivance for Severe Oral Mucositis in Cancer Patients Undergoing Bone Marrow Transplant; Pivotal Phase 3 Study Published in This Week's New England Journal of Medicine Read more about FDA Approves Kepivance for Severe Oral Mucositis in Cancer Patients Undergoing Bone Marrow Transplant; Pivotal Phase 3 Study Published in This Week's New England Journal of Medicine
Amgen Names Willard Dere Senior Vice President, Global Development Read more about Amgen Names Willard Dere Senior Vice President, Global Development
Randomized Head-to-Head Trial Shows Aranesp Dosed Every Two Weeks is Comparable to Epoetin Alfa Dosed Once a Week in Breast Cancer Patients Read more about Randomized Head-to-Head Trial Shows Aranesp Dosed Every Two Weeks is Comparable to Epoetin Alfa Dosed Once a Week in Breast Cancer Patients
